Literature DB >> 21900524

Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatment.

Shudan Chen, Fupin Hu, Xuelian Zhang, Xiaogang Xu, Yang Liu, Demei Zhu, Honghai Wang.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21900524      PMCID： PMC3209074          DOI： 10.1128/JCM.01233-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation.

Authors:  Göran Kronvall; Inga Karlsson; Mats Walder; Mikael Sörberg; Lennart E Nilsson
Journal:  J Antimicrob Chemother       Date:  2006-01-12       Impact factor: 5.790

2.  Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection.

Authors:  Jooyun Lee; Gopi Patel; Shirish Huprikar; David P Calfee; Stephen G Jenkins
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

3.  Porin expression in clinical isolates of Klebsiella pneumoniae.

Authors:  Santiago Hernández-Allés; Sebastián Albertí; Dolores Álvarez; Antonio Doménech-Sánchez; Luis Martínez-Martínez; José Gil; Juan M Tomás; Vicente J Benedí
Journal:  Microbiology       Date:  1999-03       Impact factor: 2.777

4.  Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster.

Authors:  Anastasia Antoniadou; Flora Kontopidou; Garifalia Poulakou; Evangelos Koratzanis; Irene Galani; Evangelos Papadomichelakis; Petros Kopterides; Maria Souli; Apostolos Armaganidis; Helen Giamarellou
Journal:  J Antimicrob Chemother       Date:  2007-02-16       Impact factor: 5.790

5.  Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Authors:  Simona Bratu; David Landman; Robin Haag; Rose Recco; Antonella Eramo; Maqsood Alam; John Quale
Journal:  Arch Intern Med       Date:  2005-06-27
  5 in total
  10 in total

Review 1.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

Review 2.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

3.  Antimicrobial Activity of Colistin Against Contemporary (2015 - 2017) P. aeruginosa and A. baumannii Isolates From a Chinese Surveillance Program.

Authors:  Hui Zhang; Ge Zhang; Jingjia Zhang; Simeng Duan; Yue Kang; Qiwen Yang; Yingchun Xu
Journal:  Front Microbiol       Date:  2020-09-04       Impact factor: 5.640

4.  Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.

Authors:  Patricia A Bradford; Krystyna M Kazmierczak; Douglas J Biedenbach; Mark G Wise; Meredith Hackel; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

5.  Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014.

Authors:  Saverio Giuseppe Parisi; Andrea Bartolini; Erica Santacatterina; Elena Castellani; Roberto Ghirardo; Alessandro Berto; Elisa Franchin; Nicola Menegotto; Ettore De Canale; Tiziana Tommasini; Roberto Rinaldi; Monica Basso; Stefania Stefani; Giorgio Palù
Journal:  BMC Infect Dis       Date:  2015-06-27       Impact factor: 3.090

6.  A Study of 24 Patients with Colistin-Resistant Gram-negative Isolates in a Tertiary Care Hospital in South India.

Authors:  Rajalakshmi Arjun; Ram Gopalakrishnan; P Senthur Nambi; D Suresh Kumar; R Madhumitha; V Ramasubramanian
Journal:  Indian J Crit Care Med       Date:  2017-05

7.  Analysis of Susceptibilities of Carbapenem Resistant Enterobacterales to Colistin in Intra-Abdominal, Respiratory and Urinary Tract Infections from 2015 to 2017.

Authors:  Hui Zhang; Jingjia Zhang; Yue Kang; Qiwen Yang; Yingchun Xu
Journal:  Infect Drug Resist       Date:  2020-06-23       Impact factor: 4.003

8.  Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection.

Authors:  W Wangchinda; N Pati; N Maknakhon; C Seenama; S Tiengrim; V Thamlikitkul
Journal:  Antimicrob Resist Infect Control       Date:  2018-07-17       Impact factor: 4.887

9.  Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections.

Authors:  Anushree Ulhas Amladi; Baby Abirami; S Manjula Devi; Thambu David Sudarsanam; Subramani Kandasamy; Nitin Kekre; Balaji Veeraraghavan; Rani Diana Sahni
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

10.  Comparison of Six Phenotypic Assays with Reference Methods for Assessing Colistin Resistance in Clinical Isolates of Carbapenemase-Producing Enterobacterales: Challenges and Opportunities.

Authors:  Annamária Főldes; Edit Székely; Septimiu Toader Voidăzan; Minodora Dobreanu
Journal:  Antibiotics (Basel)       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.